Federal Trade Commission Questions Mylan on EpiPen

Mylan said it received a “preliminary” inquiry from the Federal Trade Commission asking about the company’s commercial practices for its EpiPen severe-allergy treatments.

from WSJ.com: US Business http://ift.tt/2kaoarr
via IFTTT